Sensus Healthcare, Inc. (SRTS): Price and Financial Metrics

Sensus Healthcare, Inc. (SRTS): $8.01

-0.24 (-2.91%)

POWR Rating

Component Grades














  • Sentiment is the dimension where SRTS ranks best; there it ranks ahead of 98.86% of US stocks.
  • The strongest trend for SRTS is in Quality, which has been heading up over the past 97 days.
  • SRTS's current lowest rank is in the Stability metric (where it is better than 3.43% of US stocks).

SRTS Stock Summary

  • With a year-over-year growth in debt of -83.72%, Sensus Healthcare Inc's debt growth rate surpasses only 2.74% of about US stocks.
  • As for revenue growth, note that SRTS's revenue has grown 182.37% over the past 12 months; that beats the revenue growth of 95.54% of US companies in our set.
  • In terms of volatility of its share price, SRTS is more volatile than 94.54% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Sensus Healthcare Inc, a group of peers worth examining would be WSTL, OSPN, BKYI, IRBT, and SOFO.
  • SRTS's SEC filings can be seen here. And to visit Sensus Healthcare Inc's official web site, go to

SRTS Valuation Summary

  • In comparison to the median Healthcare stock, SRTS's price/earnings ratio is 178.36% lower, now standing at -28.6.
  • SRTS's price/sales ratio has moved down 2.5 over the prior 62 months.
  • Over the past 62 months, SRTS's price/earnings ratio has gone up 510.7.

Below are key valuation metrics over time for SRTS.

Stock Date P/S P/B P/E EV/EBIT
SRTS 2021-08-31 3.9 2.9 -28.6 -21.8
SRTS 2021-08-30 4.0 3.0 -29.3 -22.4
SRTS 2021-08-27 4.0 3.0 -29.4 -22.5
SRTS 2021-08-26 3.9 2.9 -28.5 -21.7
SRTS 2021-08-25 3.9 3.0 -29.0 -22.2
SRTS 2021-08-24 3.8 2.9 -28.0 -21.2

SRTS Price Target

For more insight on analysts targets of SRTS, see our SRTS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.43 Average Broker Recommendation 1.5 (Moderate Buy)

SRTS Stock Price Chart Interactive Chart >

Price chart for SRTS

SRTS Price/Volume Stats

Current price $8.01 52-week high $11.96
Prev. close $8.25 52-week low $3.21
Day low $7.97 Volume 80,200
Day high $8.42 Avg. volume 293,102
50-day MA $8.19 Dividend yield N/A
200-day MA $7.36 Market Cap 133.59M

Sensus Healthcare, Inc. (SRTS) Company Bio

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is based in Boca Raton, Florida.

SRTS Latest News Stream

Event/Time News Detail
Loading, please wait...

SRTS Latest Social Stream

Loading social stream, please wait...

View Full SRTS Social Stream

Latest SRTS News From Around the Web

Below are the latest news stories about Sensus Healthcare Inc that investors may wish to consider to help them evaluate SRTS as an investment opportunity.

Sensus Healthcare, Inc. (SRTS) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Yahoo | February 18, 2022

Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 10, 2022

Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter

4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for oncological and non-oncological conditions, announces financ

Yahoo | February 10, 2022

VeriSign (VRSN) to Report Q4 Earnings: What's in Store?

Higher .com and .net domain name registrations supported by a recovering global economy might have aided VeriSign's (VRSN) performance in the fourth quarter of 2021.

Yahoo | February 8, 2022

Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 3, 2022

Read More 'SRTS' Stories Here

SRTS Price Returns

1-mo N/A
3-mo -20.85%
6-mo 10.94%
1-year 88.47%
3-year 44.58%
5-year 99.25%
YTD 10.94%
2021 87.05%
2020 9.04%
2019 -52.23%
2018 43.60%
2017 -1.71%

Continue Researching SRTS

Want to see what other sources are saying about Sensus Healthcare Inc's financials and stock price? Try the links below:

Sensus Healthcare Inc (SRTS) Stock Price | Nasdaq
Sensus Healthcare Inc (SRTS) Stock Quote, History and News - Yahoo Finance
Sensus Healthcare Inc (SRTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5789 seconds.